Cargando…

Pharmaceuticals and Environment: a web-based decision support for considering environmental aspects of medicines in use

PURPOSE: The database Pharmaceuticals and Environment is a non-commercial, freely available web-based decision support presenting compiled environmental information for pharmaceutical substances. It was developed by Region Stockholm and launched in 2016 at janusinfo.se. The purpose of this paper is...

Descripción completa

Detalles Bibliográficos
Autores principales: Ramström, Helena, Martini, Siv, Borgendahl, Johanna, Ågerstrand, Marlene, Lärfars, Gerd, Ovesjö, Marie-Louise
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7351842/
https://www.ncbi.nlm.nih.gov/pubmed/32388641
http://dx.doi.org/10.1007/s00228-020-02885-1
_version_ 1783557526403416064
author Ramström, Helena
Martini, Siv
Borgendahl, Johanna
Ågerstrand, Marlene
Lärfars, Gerd
Ovesjö, Marie-Louise
author_facet Ramström, Helena
Martini, Siv
Borgendahl, Johanna
Ågerstrand, Marlene
Lärfars, Gerd
Ovesjö, Marie-Louise
author_sort Ramström, Helena
collection PubMed
description PURPOSE: The database Pharmaceuticals and Environment is a non-commercial, freely available web-based decision support presenting compiled environmental information for pharmaceutical substances. It was developed by Region Stockholm and launched in 2016 at janusinfo.se. The purpose of this paper is to present the database, report on its current use, and reflect on lessons learned from developing and managing the database. METHODS: A standard operating procedure describes the work and content of the database, e.g., how information is retrieved, processed, and presented. Google Analytics was used for metrics. Issues related to the database have been discussed and handled by a reference group. The experiences from this work are presented. RESULTS: The database contains environmental hazard and risk information, primarily gathered from regulatory authorities and pharmaceutical companies. There are also assessments comparing substances within some groups of pharmaceuticals. The database is used by the Swedish Drug and Therapeutics Committees to include environmental aspects when recommending pharmaceuticals for health care providers. Page views show that users primarily look for information on commonly used substances, e.g., diclofenac and paracetamol/acetaminophen. Major problems for the development of the database are lack of data, lack of transparency, and discrepancies in the available environmental information. CONCLUSION: In the absence of an adequate decision support produced by the regulatory authorities, we find the database Pharmaceuticals and Environment to be useful for Swedish Drug and Therapeutics Committees and health care providers, and it is our belief that the information can be valuable also in other settings.
format Online
Article
Text
id pubmed-7351842
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-73518422020-07-14 Pharmaceuticals and Environment: a web-based decision support for considering environmental aspects of medicines in use Ramström, Helena Martini, Siv Borgendahl, Johanna Ågerstrand, Marlene Lärfars, Gerd Ovesjö, Marie-Louise Eur J Clin Pharmacol Pharmacoepidemiology and Prescription PURPOSE: The database Pharmaceuticals and Environment is a non-commercial, freely available web-based decision support presenting compiled environmental information for pharmaceutical substances. It was developed by Region Stockholm and launched in 2016 at janusinfo.se. The purpose of this paper is to present the database, report on its current use, and reflect on lessons learned from developing and managing the database. METHODS: A standard operating procedure describes the work and content of the database, e.g., how information is retrieved, processed, and presented. Google Analytics was used for metrics. Issues related to the database have been discussed and handled by a reference group. The experiences from this work are presented. RESULTS: The database contains environmental hazard and risk information, primarily gathered from regulatory authorities and pharmaceutical companies. There are also assessments comparing substances within some groups of pharmaceuticals. The database is used by the Swedish Drug and Therapeutics Committees to include environmental aspects when recommending pharmaceuticals for health care providers. Page views show that users primarily look for information on commonly used substances, e.g., diclofenac and paracetamol/acetaminophen. Major problems for the development of the database are lack of data, lack of transparency, and discrepancies in the available environmental information. CONCLUSION: In the absence of an adequate decision support produced by the regulatory authorities, we find the database Pharmaceuticals and Environment to be useful for Swedish Drug and Therapeutics Committees and health care providers, and it is our belief that the information can be valuable also in other settings. Springer Berlin Heidelberg 2020-05-09 2020 /pmc/articles/PMC7351842/ /pubmed/32388641 http://dx.doi.org/10.1007/s00228-020-02885-1 Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Pharmacoepidemiology and Prescription
Ramström, Helena
Martini, Siv
Borgendahl, Johanna
Ågerstrand, Marlene
Lärfars, Gerd
Ovesjö, Marie-Louise
Pharmaceuticals and Environment: a web-based decision support for considering environmental aspects of medicines in use
title Pharmaceuticals and Environment: a web-based decision support for considering environmental aspects of medicines in use
title_full Pharmaceuticals and Environment: a web-based decision support for considering environmental aspects of medicines in use
title_fullStr Pharmaceuticals and Environment: a web-based decision support for considering environmental aspects of medicines in use
title_full_unstemmed Pharmaceuticals and Environment: a web-based decision support for considering environmental aspects of medicines in use
title_short Pharmaceuticals and Environment: a web-based decision support for considering environmental aspects of medicines in use
title_sort pharmaceuticals and environment: a web-based decision support for considering environmental aspects of medicines in use
topic Pharmacoepidemiology and Prescription
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7351842/
https://www.ncbi.nlm.nih.gov/pubmed/32388641
http://dx.doi.org/10.1007/s00228-020-02885-1
work_keys_str_mv AT ramstromhelena pharmaceuticalsandenvironmentawebbaseddecisionsupportforconsideringenvironmentalaspectsofmedicinesinuse
AT martinisiv pharmaceuticalsandenvironmentawebbaseddecisionsupportforconsideringenvironmentalaspectsofmedicinesinuse
AT borgendahljohanna pharmaceuticalsandenvironmentawebbaseddecisionsupportforconsideringenvironmentalaspectsofmedicinesinuse
AT agerstrandmarlene pharmaceuticalsandenvironmentawebbaseddecisionsupportforconsideringenvironmentalaspectsofmedicinesinuse
AT larfarsgerd pharmaceuticalsandenvironmentawebbaseddecisionsupportforconsideringenvironmentalaspectsofmedicinesinuse
AT ovesjomarielouise pharmaceuticalsandenvironmentawebbaseddecisionsupportforconsideringenvironmentalaspectsofmedicinesinuse